GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Common Stock

CellSource Co (TSE:4880) Common Stock : 円1,426 Mil (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Common Stock?

CellSource Co's quarterly common stock increased from Jul. 2023 (円694 Mil) to Oct. 2023 (円1,425 Mil) and increased from Oct. 2023 (円1,425 Mil) to Jan. 2024 (円1,426 Mil).

CellSource Co's annual common stock increased from Oct. 2021 (円679 Mil) to Oct. 2022 (円689 Mil) and increased from Oct. 2022 (円689 Mil) to Oct. 2023 (円1,425 Mil).


CellSource Co Common Stock Historical Data

The historical data trend for CellSource Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Common Stock Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Common Stock
Get a 7-Day Free Trial 593.42 672.82 679.12 689.23 1,425.40

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 690.88 690.88 694.12 1,425.40 1,426.47

CellSource Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines